{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:45:58Z","timestamp":1787060758058,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-83193-x","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T22:40:35Z","timestamp":1735857635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of linsitinib on M22 and IGF:1-treated 3D spheroids of human orbital fibroblasts"],"prefix":"10.1038","volume":"15","author":[{"given":"Fumihito","family":"Hikage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araya","family":"Umetsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nami","family":"Nishikiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ohguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"83193_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","volume":"6","author":"TF Davies","year":"2020","unstructured":"Davies, T. F. et al. Graves\u2019 disease.. Nat. Rev. Dis. Primers. 6, 52. https:\/\/doi.org\/10.1038\/s41572-020-0184-y (2020).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"83193_CR2","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","volume":"375","author":"TJ Smith","year":"2016","unstructured":"Smith, T. J. & Heged\u00fcs, L. Graves\u2019 disease. N. Engl. J. Med. 375, 1552\u20131565. https:\/\/doi.org\/10.1056\/NEJMra1510030 (2016).","journal-title":"N. Engl. J. Med."},{"key":"83193_CR3","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn, R. S. Graves\u2019 ophthalmopathy. N. Engl. J. Med. 362, 726\u2013738. https:\/\/doi.org\/10.1056\/NEJMra0905750 (2010).","journal-title":"N. Engl. J. Med."},{"key":"83193_CR4","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1210\/en.2017-00528","volume":"158","author":"CC Krieger","year":"2017","unstructured":"Krieger, C. C., Perry, J. D., Morgan, S. J., Kahaly, G. J. & Gershengorn, M. C. TSH\/IGF-1 receptor cross-talk rapidly activates extracellular signal-regulated kinases in multiple cell types. Endocrinology 158, 3676\u20133683. https:\/\/doi.org\/10.1210\/en.2017-00528 (2017).","journal-title":"Endocrinology"},{"key":"83193_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.exer.2015.02.007","volume":"142","author":"WA Dik","year":"2016","unstructured":"Dik, W. A., Virakul, S. & van Steensel, L. Current perspectives on the role of orbital fibroblasts in the pathogenesis of graves\u2019 ophthalmopathy. Exp. Eye Res. 142, 83\u201391. https:\/\/doi.org\/10.1016\/j.exer.2015.02.007 (2016).","journal-title":"Exp. Eye Res."},{"key":"83193_CR6","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1210\/jc.2013-1149","volume":"98","author":"AF Turcu","year":"2013","unstructured":"Turcu, A. F. et al. A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of graves ophthalmopathy. J Clin. Endocrinol. Metab. 98, 2153\u20132159. https:\/\/doi.org\/10.1210\/jc.2013-1149 (2013).","journal-title":"J Clin. Endocrinol. Metab."},{"key":"83193_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrendo.2014.226","volume":"11","author":"TJ Smith","year":"2015","unstructured":"Smith, T. J. TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy. Nature reviews Endocrinology 11, 171\u2013181. https:\/\/doi.org\/10.1038\/nrendo.2014.226 (2015).","journal-title":"Nature reviews Endocrinology"},{"key":"83193_CR8","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1038\/s41467-019-12564-0","volume":"10","author":"J Li","year":"2019","unstructured":"Li, J., Choi, E., Yu, H. & Bai, X. C. Structural basis of the activation of type 1 insulin-like growth factor receptor. Nat. Commun. 10, 4567. https:\/\/doi.org\/10.1038\/s41467-019-12564-0 (2019).","journal-title":"Nat. Commun."},{"key":"83193_CR9","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.4155\/fmc.09.89","volume":"1","author":"MJ Mulvihill","year":"2009","unstructured":"Mulvihill, M. J. et al. Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor. Future. medicinal chemistry 1, 1153\u20131171. https:\/\/doi.org\/10.4155\/fmc.09.89 (2009).","journal-title":"Future. medicinal chemistry"},{"key":"83193_CR10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1158\/1078-0432.Ccr-14-0303","volume":"21","author":"I Puzanov","year":"2015","unstructured":"Puzanov, I. et al. A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumors. Clinical cancer research\u202f: an official journal of the American Association for Cancer Research 21, 701\u2013711. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-14-0303 (2015).","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"83193_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1210\/er.2018-00066","volume":"40","author":"TJ Smith","year":"2019","unstructured":"Smith, T. J. & Janssen, J. Insulin-like growth factor-I receptor and thyroid-associated ophthalmopathy. Endocrine reviews 40, 236\u2013267. https:\/\/doi.org\/10.1210\/er.2018-00066 (2019).","journal-title":"Endocrine reviews"},{"key":"83193_CR12","doi-asserted-by":"publisher","first-page":"1211473","DOI":"10.3389\/fendo.2023.1211473","volume":"14","author":"A Gulbins","year":"2023","unstructured":"Gulbins, A. et al. Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease. Frontiers in endocrinology 14, 1211473. https:\/\/doi.org\/10.3389\/fendo.2023.1211473 (2023).","journal-title":"Frontiers in endocrinology"},{"key":"83193_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1210\/en.2018-00272","volume":"160","author":"F Hikage","year":"2019","unstructured":"Hikage, F., Atkins, S., Kahana, A., Smith, T. J. & Chun, T. H. HIF2A-LOX pathway promotes fibrotic tissue remodeling in thyroid-associated orbitopathy. Endocrinology 160, 20\u201335. https:\/\/doi.org\/10.1210\/en.2018-00272 (2019).","journal-title":"Endocrinology"},{"key":"83193_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108489","author":"H Ichioka","year":"2021","unstructured":"Ichioka, H., Ida, Y., Watanabe, M., Ohguro, H. & Hikage, F. Prostaglandin F2\u03b1 and EP2 agonists, and a ROCK inhibitor modulate the formation of 3D organoids of grave\u2019s orbitopathy related human orbital fibroblasts. Exp. Eye. Res. https:\/\/doi.org\/10.1016\/j.exer.2021.108489 (2021).","journal-title":"Exp. Eye. Res."},{"key":"83193_CR15","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1210\/jc.2014-3566","volume":"100","author":"CC Krieger","year":"2015","unstructured":"Krieger, C. C., Neumann, S., Place, R. F., Marcus-Samuels, B. & Gershengorn, M. C. Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by graves\u2019 disease immunoglobins. J. Clin. Endocrinol Metab 100, 1071\u20131077. https:\/\/doi.org\/10.1210\/jc.2014-3566 (2015).","journal-title":"J. Clin. Endocrinol Metab"},{"key":"83193_CR16","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","volume":"181","author":"S Tsui","year":"2008","unstructured":"Tsui, S. et al. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in grave\u2019s disease. Journal of immunology (Baltimore Md: 1950) 181, 4397\u20134405. https:\/\/doi.org\/10.4049\/jimmunol.181.6.4397 (2008).","journal-title":"Journal of immunology (Baltimore Md: 1950)"},{"key":"83193_CR17","doi-asserted-by":"publisher","first-page":"E1183","DOI":"10.1210\/jc.2013-4182","volume":"99","author":"L Zhang","year":"2014","unstructured":"Zhang, L. et al. Possible targets for nonimmunosuppressive therapy of graves\u2019 orbitopathy. J. Clin. Endocrinol Metab 99, E1183-1190. https:\/\/doi.org\/10.1210\/jc.2013-4182 (2014).","journal-title":"J. Clin. Endocrinol Metab"},{"key":"83193_CR18","doi-asserted-by":"publisher","first-page":"7958","DOI":"10.1038\/s41598-020-64674-1","volume":"10","author":"Y Ida","year":"2020","unstructured":"Ida, Y., Hikage, F., Itoh, K., Ida, H. & Ohguro, H. Prostaglandin F2\u03b1 agonist-induced suppression of 3T3-L1 cell adipogenesis affects spatial formation of extra-cellular matrix. Sci. Rep. 10, 7958. https:\/\/doi.org\/10.1038\/s41598-020-64674-1 (2020).","journal-title":"Sci. Rep."},{"key":"83193_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/iovs.61.6.13","volume":"61","author":"K Itoh","year":"2020","unstructured":"Itoh, K., Hikage, F., Ida, Y. & Ohguro, H. Prostaglandin F2\u03b1 agonists negatively modulate the size of 3D organoids from primary human orbital fibroblasts. Invest. Ophthalmol. Vis. Sci. 61, 13. https:\/\/doi.org\/10.1167\/iovs.61.6.13 (2020).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"83193_CR20","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1016\/S0021-9258(18)61309-2","volume":"262","author":"P Santisteban","year":"1987","unstructured":"Santisteban, P., Kohn, L. D. & Di Lauro, R. Thyroglobulin gene expression is regulated by insulin and insulin-like growth factor I, as well as thyrotropin, in FRTL-5 thyroid cells. J. Biol. Chem. 262, 4048\u20134052 (1987).","journal-title":"J. Biol. Chem."},{"key":"83193_CR21","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1089\/1050725041692918","volume":"14","author":"J Sanders","year":"2004","unstructured":"Sanders, J. et al. Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. Thyroid\u202f: official journal of the American Thyroid Association 14, 560\u2013570. https:\/\/doi.org\/10.1089\/1050725041692918 (2004).","journal-title":"Thyroid : official journal of the American Thyroid Association"},{"key":"83193_CR22","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1089\/thy.2017.0281","volume":"27","author":"TJ Smith","year":"2017","unstructured":"Smith, T. J. et al. re: \"TSHR\/IGF-1R cross-talk, not IGF-1R stimulating antibodies, mediates graves\u2019 ophthalmopathy pathogenesis\" (thyroid 2017;27:746\u2013747). Thyroid\u202f: official journal of the American Thyroid Association 27, 1458\u20131459. https:\/\/doi.org\/10.1089\/thy.2017.0281 (2017).","journal-title":"Thyroid : official journal of the American Thyroid Association"},{"key":"83193_CR23","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1089\/thy.2017.0472","volume":"27","author":"S Neumann","year":"2017","unstructured":"Neumann, S. & Gershengorn, M. C. Rebuttal to smith and janssen (thyroid 2017;27:746\u2013747. DOI: 10.1089\/thy.2017.0281). Thyroid\u202f: official journal of the American Thyroid Association 27, 1459\u20131460. https:\/\/doi.org\/10.1089\/thy.2017.0472 (2017).","journal-title":"Thyroid : official journal of the American Thyroid Association"},{"key":"83193_CR24","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1210\/jc.2016-1315","volume":"101","author":"CC Krieger","year":"2016","unstructured":"Krieger, C. C. et al. TSH\/IGF-1 receptor cross talk in graves\u2019 ophthalmopathy pathogenesis. J. Clin. Endocrinol. Metab. 101, 2340\u20132347. https:\/\/doi.org\/10.1210\/jc.2016-1315 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"83193_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/s0305-0491(98)10106-2","volume":"121","author":"AA Butler","year":"1998","unstructured":"Butler, A. A. et al. Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology. Comparative biochemistry and physiology Part B, Biochemistry & molecular biology 121, 19\u201326. https:\/\/doi.org\/10.1016\/s0305-0491(98)10106-2 (1998).","journal-title":"Comparative biochemistry and physiology Part B, Biochemistry & molecular biology"},{"key":"83193_CR26","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1089\/thy.2018.0089","volume":"28","author":"B Marcus-Samuels","year":"2018","unstructured":"Marcus-Samuels, B. et al. Evidence that graves\u2019 ophthalmopathy immunoglobulins do not directly activate IGF-1 receptors. Thyroid\u202f: official journal of the American Thyroid Association 28, 650\u2013655. https:\/\/doi.org\/10.1089\/thy.2018.0089 (2018).","journal-title":"Thyroid : official journal of the American Thyroid Association"},{"key":"83193_CR27","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1089\/thy.2007.0170","volume":"17","author":"B Rapoport","year":"2007","unstructured":"Rapoport, B. & McLachlan, S. M. The thyrotropin receptor in graves\u2019 disease. Thyroid\u202f: official journal of the American Thyroid Association 17, 911\u2013922. https:\/\/doi.org\/10.1089\/thy.2007.0170 (2007).","journal-title":"Thyroid : official journal of the American Thyroid Association"},{"key":"83193_CR28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.beem.2011.10.002","volume":"26","author":"TJ Smith","year":"2012","unstructured":"Smith, T. J., Heged\u00fcs, L. & Douglas, R. S. Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of graves\u2019 orbitopathy. Best practice & research Clinical endocrinology & metabolism 26, 291\u2013302. https:\/\/doi.org\/10.1016\/j.beem.2011.10.002 (2012).","journal-title":"Best practice & research Clinical endocrinology & metabolism"},{"key":"83193_CR29","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.1210\/jc.2004-0716","volume":"89","author":"TJ Smith","year":"2004","unstructured":"Smith, T. J. & Hoa, N. Immunoglobulins from patients with Graves\u2019 disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor. J. Clin. Endocrinol. Metab. 89, 5076\u20135080. https:\/\/doi.org\/10.1210\/jc.2004-0716 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"83193_CR30","doi-asserted-by":"publisher","first-page":"19369","DOI":"10.1038\/s41598-021-98766-3","volume":"11","author":"M Watanabe","year":"2021","unstructured":"Watanabe, M., Ida, Y., Ohguro, H., Ota, C. & Hikage, F. Establishment of appropriate glaucoma models using dexamethasone or TGF\u03b22 treated three-dimension (3D) cultured human trabecular meshwork (HTM) cells. Sci. Rep. 11, 19369. https:\/\/doi.org\/10.1038\/s41598-021-98766-3 (2021).","journal-title":"Sci. Rep."},{"key":"83193_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105473","author":"S Suzuki","year":"2022","unstructured":"Suzuki, S. et al. Hypoxia differently affects TGF-\u03b22-induced epithelial mesenchymal transitions in the 2D and 3D culture of the human retinal pigment epithelium cells. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms23105473 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"83193_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11092513","author":"A Umetsu","year":"2023","unstructured":"Umetsu, A. et al. TGF-\u03b22 induces epithelial-mesenchymal transitions in 2D planer and 3D spheroids of the human corneal stroma fibroblasts in different manners. Biomedicines https:\/\/doi.org\/10.3390\/biomedicines11092513 (2023).","journal-title":"Biomedicines"},{"key":"83193_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.989626","volume":"13","author":"CC Krieger","year":"2022","unstructured":"Krieger, C. C., Boutin, A., Neumann, S. & Gershengorn, M. C. Proximity ligation assay to study TSH receptor homodimerization and crosstalk with IGF-1 receptors in human thyroid cells. Frontiers in endocrinology 13, 989626. https:\/\/doi.org\/10.3389\/fendo.2022.989626 (2022).","journal-title":"Frontiers in endocrinology"},{"key":"83193_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cells13181549","author":"H Ohguro","year":"2024","unstructured":"Ohguro, H. et al. Application of single cell type-derived spheroids generated by using a hanging drop culture technique in various In vitro disease models: a narrow review. Cells https:\/\/doi.org\/10.3390\/cells13181549 (2024).","journal-title":"Cells"},{"key":"83193_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cells11020300","author":"H Ohguro","year":"2022","unstructured":"Ohguro, H. et al. STAT3 Is the master regulator for the forming of 3D spheroids of 3T3-L1 preadipocytes. Cells https:\/\/doi.org\/10.3390\/cells11020300 (2022).","journal-title":"Cells"},{"key":"83193_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20713","volume":"9","author":"K Endo","year":"2023","unstructured":"Endo, K. et al. 3D culture induction of adipogenic differentiation in 3T3-L1 preadipocytes exhibits adipocyte-specific molecular expression patterns and metabolic functions. Heliyon 9, e20713. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20713 (2023).","journal-title":"Heliyon"},{"key":"83193_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411459","author":"M Watanabe","year":"2023","unstructured":"Watanabe, M. et al. mTOR Inhibitors modulate the physical properties of 3D spheroids derived from H9c2 cells. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms241411459 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"83193_CR38","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1158\/1078-0432.Ccr-14-2518","volume":"21","author":"WT Iams","year":"2015","unstructured":"Iams, W. T. & Lovly, C. M. Molecular pathways: clinical applications and future direction of insulin-like growth factor-1 receptor pathway blockade. Clinical cancer research\u202f: an official journal of the American Association for Cancer Research 21, 4270\u20134277. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-14-2518 (2015).","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"83193_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s12672-011-0090-6","volume":"2","author":"MJ Demeure","year":"2011","unstructured":"Demeure, M. J., Bussey, K. J. & Kirschner, L. S. Targeted therapies for adrenocortical carcinoma: IGF and beyond. Hormones & cancer 2, 385\u2013392. https:\/\/doi.org\/10.1007\/s12672-011-0090-6 (2011).","journal-title":"Hormones & cancer"},{"key":"83193_CR40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ctrv.2011.07.008","volume":"38","author":"GV Scagliotti","year":"2012","unstructured":"Scagliotti, G. V. & Novello, S. The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors. Cancer treatment reviews 38, 292\u2013302. https:\/\/doi.org\/10.1016\/j.ctrv.2011.07.008 (2012).","journal-title":"Cancer treatment reviews"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83193-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83193-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83193-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T01:34:04Z","timestamp":1735868044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-83193-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["83193"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-83193-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"384"}}